{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T07:39:49Z","timestamp":1794037189968,"version":"4.8.0"},"reference-count":22,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T00:00:00Z","timestamp":1675814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>According to the World Health Organization, 83,339 laboratory-confirmed cases, including 72 deaths, of mpox (formerly known as monkeypox), have been reported from 110 locations globally as of 20 December 2022, making the disease a public health concern. Most of the cases (56,171, 67.4%) were reported from countries in North America. Limited data on vaccine effectiveness in the current mpox outbreak are available. However, the modified vaccinia virus (smallpox vaccine) has been predicted to prevent or reduce the severity of the mpox infection. The present study of systematic review and meta-analysis aimed to evaluate the modified vaccinia vaccine\u2019s safety and efficacy on mpox by using reported randomized clinical trials. Following guidelines from the Cochrane Collaboration and PRISMA, multiple databases including PubMed, PLOS ONE, Google Scholar, British Medical Journal, and the U. S. National Library of Medicine were searched. Out of 13,294 research articles initially identified, 187 were screened after removing duplicates. Following the inclusion and exclusion criteria, the meta-analysis included ten studies with 7430 patients. Three researchers independently assessed the risk of bias in the included study. The pooled results suggest that the vaccinia-exposed group had fewer side effects when compared to the vaccinia na\u00efve group (odds ratio: 1.66; 95% CI: 1.07\u20132.57; p = 0.03). Overall, the modified vaccinia has proven safe and effective in both vaccinia na\u00efve and previously exposed groups, with higher efficacy in the previously exposed groups.<\/jats:p>","DOI":"10.3390\/ijerph20042963","type":"journal-article","created":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T04:57:41Z","timestamp":1675832261000},"page":"2963","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Safety and Efficacy of Post-Eradication Smallpox Vaccine as an Mpox Vaccine: A Systematic Review with Meta-Analysis"],"prefix":"10.3390","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9899-0898","authenticated-orcid":false,"given":"Shelia","family":"Malone","sequence":"first","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Public Health, College of Health Sciences, Jackson State University, Jackson, MS 39217, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4238-7322","authenticated-orcid":false,"given":"Amal","family":"Mitra","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Public Health, College of Health Sciences, Jackson State University, Jackson, MS 39217, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nwanne","family":"Onumah","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Public Health, College of Health Sciences, Jackson State University, Jackson, MS 39217, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Brown","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Public Health, College of Health Sciences, Jackson State University, Jackson, MS 39217, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Jones","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Public Health, College of Health Sciences, Jackson State University, Jackson, MS 39217, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9558-7425","authenticated-orcid":false,"given":"Da\u2019Chirion","family":"Tresvant","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Public Health, College of Health Sciences, Jackson State University, Jackson, MS 39217, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cagney","family":"Brown","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Public Health, College of Health Sciences, Jackson State University, Jackson, MS 39217, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austine","family":"Onyia","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Public Health, College of Health Sciences, Jackson State University, Jackson, MS 39217, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faith","family":"Iseguede","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Public Health, College of Health Sciences, Jackson State University, Jackson, MS 39217, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,8]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2020, January 01). 2022 Mpox (Monkeypox) Outbreak: Global Trends. Available online: https:\/\/worldhealthorg.shinyapps.io\/mpx_global\/."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3883822","DOI":"10.1155\/2022\/3883822","article-title":"Comparison of Transcriptomic Signatures between Monkeypox-Infected Monkey and Human Cell Lines","volume":"2022","author":"Xuan","year":"2022","journal-title":"J. Immunol. Res."},{"key":"ref_3","first-page":"2200503","article-title":"Frequent detection of monkeypox virus DNA in saliva, semen, and other clinical samples from 12 patients, Barcelona, Spain, May to June 2022","volume":"27","author":"Fuertes","year":"2022","journal-title":"Eurosurveillance"},{"key":"ref_4","unstructured":"Center for Disease Control and Prevention (2020, January 01). Smallpox, Available online: https:\/\/www.cdc.gov\/smallpox\/vaccine-basics\/vaccination-effects.html."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"961","DOI":"10.4161\/hv.21080","article-title":"A vaccinia virus renaissance: New vaccine and immunotherapeutic uses after smallpox eradication","volume":"8","author":"Verardi","year":"2012","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_6","unstructured":"Center for Disease Control and Prevention (2020, January 01). \u201cMonkeypox in the U.S.\u201d Centers for Disease Control and Prevention, 30 August 2022, Available online: www.cdc.gov\/poxvirus\/monkeypox\/vaccines\/vaccine-basics.html."},{"key":"ref_7","unstructured":"Higgins, J.P.T., and Green, S. (2011). Cochrane Handbook for Systematic Reviews of Interventions, Wiley."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Greenberg, R.N., Hurley, M.Y., Dinh, D.V., Mraz, S., Vera, J.G., von Bredow, D., von Krempelhuber, A., Roesch, S., Virgin, G., and Arndtz-Wiedemann, N. (2015). A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18\u201340 Year Old Subjects with Diagnosed Atopic Dermatitis. PLoS ONE, 10, Erratum in PLoS ONE 2015, 10, e0142802.","DOI":"10.1371\/journal.pone.0142802"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1086\/651560","article-title":"Effect of vaccination with modified vaccinia Ankara (ACAM3000) on subsequent challenge with Dryvax","volume":"201","author":"Seaman","year":"2010","journal-title":"J. Infect. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Overton, E.T., Lawrence, S.J., Wagner, E., Nopora, K., Rosch, S., Young, P., Schmidt, D., Kreusel, C., De Carli, S., and Meyer, T.P. (2018). Immunogenicity and safety of three consecutive production lots of the non replicating smallpox vaccine MVA: A randomised, double blind, placebo controlled phase III trial. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0195897"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1056\/NEJMoa1817307","article-title":"Phase 3 Efficacy Trial of Modified Vaccinia Ankara as a Vaccine against Smallpox","volume":"381","author":"Pittman","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1016\/j.vaccine.2020.01.058","article-title":"A randomized phase II trial to compare safety and immunogenicity of the MVA-BN smallpox vaccine at various doses in adults with a history of AIDS","volume":"38","author":"Overton","year":"2020","journal-title":"Vaccine"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1093\/infdis\/jiab111","article-title":"Human Antibody Responses Following Vaccinia Immunization Using Protein Microarrays and Correlation with Cell-Mediated Immunity and Antibody-Dependent Cellular Cytotoxicity Responses","volume":"224","author":"Frey","year":"2021","journal-title":"J. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"ofv040","DOI":"10.1093\/ofid\/ofv040","article-title":"Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II Trial","volume":"2","author":"Overton","year":"2015","journal-title":"Open Forum. Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.4161\/hv.24319","article-title":"Unintentional transfer of vaccinia virus associated with smallpox vaccines","volume":"9","author":"Tack","year":"2013","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Zitzmann-Roth, E.M., von Sonnenburg, F., de la Motte, S., Arndtz-Wiedemann, N., von Krempelhuber, A., Uebler, N., Vollmar, J., Virgin, G., and Chaplin, P. (2015). Cardiac safety of Modified Vaccinia Ankara for vaccination against smallpox in a young, healthy study population. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0122653"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1001\/jama.289.24.3283","article-title":"Myopericarditis Following Smallpox Vaccination Among Vaccinia-Naive US Military Personnel","volume":"289","author":"Halsell","year":"2003","journal-title":"JAMA"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/milmed\/165.4.287","article-title":"Adverse reactions to smallpox vaccine: The Israel Defense Force experience, 1991 to 1996. A comparison with previous surveys","volume":"165","author":"Haim","year":"2000","journal-title":"Mil. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"109346","DOI":"10.1016\/j.intimp.2022.109346","article-title":"Monkeypox virus vaccine evolution and global preparedness for vaccination","volume":"113","author":"Chakraborty","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.amjmed.2008.08.019","article-title":"Immunity from smallpox vaccine persists for decades: A longitudinal study","volume":"121","author":"Taub","year":"2008","journal-title":"Am. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Poland, G.A., Kennedy, R.B., and Tosh, P.K. (2022). Prevention of Monkeypox with Vaccines: A Rapid Review. Lancet Infect. Dis.","DOI":"10.1016\/S1473-3099(22)00574-6"}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/20\/4\/2963\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:28:00Z","timestamp":1760120880000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/20\/4\/2963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,8]]},"references-count":22,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["ijerph20042963"],"URL":"https:\/\/doi.org\/10.3390\/ijerph20042963","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,8]]}}}